Gabdrakhmanov A I, Khayrullin A E, Grishin C H, Ziganshin A U
Kazan Federal (Volga Region) University, Kazan, Russia.
Kazan State Medical University, Kazan, Russia.
Int J Risk Saf Med. 2015;27 Suppl 1:S82-3. doi: 10.3233/JRS-150700.
Extracellular purine compounds, adenosine triphosphate (ATP) and adenosine, are involved in regulation of many cell functions, engaging in rapid and long-term cellular processes. The nucleotides, including ATP, exert their extracellular effects by influencing membrane P2 receptors. ATP outside of the cell rapidly is metabolized by the ecto-enzyme system to produce adenosine, which acts on separate adenosine (P1) receptors. Since adenosine and ATP often are functional antagonists, ATP degradation not only limits its effect, but also brings new ligand with different, often opposing, properties. Great variety and widespread of P2 and adenosine receptors in the body emphasize the important physiological and pathophysiological significance of these receptors, and make them very attractive as targets for potential drug action.The existence of several subtypes of P2 and adenosine receptors has been shown in the skeletal muscles. ATP as a co-transmitter is densely packed together with classical neurotransmitters in the presynaptic vesicles of vertebral motor units but until recently ATP was refused to have its own functional role there and was recognized only as a source of adenosine. However, on the eve of the third millennium there appeared data that ATP, released from the nerve ending and acting on presynaptic P2 receptors, suppresses subsequent quantum release of acetylcholine. The final product of its degradation, adenosine, performs a similar inhibitory effect acting on presynaptic adenosine receptors.Despite the fact that the mechanisms of presynaptic inhibitory action of ATP and other purines were studied earlier, the object of those studies was usually neuromuscular synapse of cold-blooded animals. The few studies, in which experiments were carried out on preparations of warm-blooded animals, described the basic effects of purines. These often were guided by the convenience of preparation of the synapses of the diaphragm. We think that those results cannot be considered as typical effects of ATP and other purines on skeletal muscles and could not be extrapolated to all warm-blooded animals. Furthermore the role of ATP and its derivatives in the accumulation of vertebrate muscular effort has not been investigated.It is known that in physiological conditions vertebrates may mobilize only up to a third of the maximum muscle force. Why the two-thirds of muscular strength are not used normally but may be used at stress, remains unknown.It is known that the body's adaptive response to stress is a change in the activity of the endocrine system. The leading role in this is given to catechol amines and glucocorticoids, mobilized in significant quantities in blood under stress.We have found previously that incubation of frog sartorius muscle with hydrocortisone resulted in a decrease of contraction amplitude. However, when hydrocortisone was used in combination with ATP, its inhibitory effect on contractile responses disappeared. It is interesting that hydrocortisone had no effect on the inhibitory effect of adenosine. In the following experiments, assessing the effect of hydrocortisone on rat soleus muscle, it was established that hydrocortisone and purines had similar inhibitory effect. When ATP and hydrocortisone were given together the same oppression occurred.
To study the effects of ATP and adenosine on contraction parameters of rat skeletal muscle and assess the impact of the catechol amines on these processes.
Contractions of rat soleus muscles were recorded isometrically by mechanical sensor Linton FSG-01 (UK) according to standard procedures. The average of muscle parameters received within 30 seconds (30 responses) was treated as one result. Amplitude and time characteristics of the curve reductions were estimated. During all experiments standard Krebs solution flowed through the bath continuously to which agents were added at necessary concentrations. All experimental animals were maintained and prepared for dissection under the European Convention for the Protection of Vertebrate Animals used in scientific experiments. All agents used in the study were supplied by Sigma Chemical Company Ltd. (UK), Tocris Cookson and Research Biochemicals International (USA).
The concentration of 100 μM for adenosine is close to saturation [1], and for its predecessor ATP this concentration is created after the passage of a pulse through the synapse [2]. We used this concentration of purines to study the mechanism of action of adenosine and ATP on neuromuscular synapse.The effect of adenosine was partially inhibited in the presence of 100 μM 8-SPT, an antagonist of adenosine receptors. The contraction force of "fast" and "slow" rat skeletal muscles was raised by half in the presence of norepinephrine. In the presence of norepinephrine adenosine exerted its effect fully, but ATP by half reduced its depressor effect on the contraction force of both muscles.
细胞外嘌呤化合物,三磷酸腺苷(ATP)和腺苷,参与许多细胞功能的调节,涉及快速和长期的细胞过程。包括ATP在内的核苷酸通过影响膜P2受体发挥其细胞外作用。细胞外的ATP迅速被胞外酶系统代谢产生腺苷,腺苷作用于不同的腺苷(P1)受体。由于腺苷和ATP通常是功能性拮抗剂,ATP的降解不仅限制了其作用,还带来了具有不同性质(通常是相反性质)的新配体。P2和腺苷受体在体内种类繁多且分布广泛,强调了这些受体重要的生理和病理生理意义,使其成为潜在药物作用的极具吸引力的靶点。
在骨骼肌中已显示存在几种P2和腺苷受体亚型。ATP作为一种共递质,与经典神经递质一起密集地包裹在脊椎动物运动单位的突触前囊泡中,但直到最近,ATP在那里一直被认为没有自身的功能作用,仅被视为腺苷的来源。然而,在第三个千年前夕,有数据表明从神经末梢释放并作用于突触前P2受体的ATP会抑制随后乙酰胆碱的量子释放。其降解的最终产物腺苷通过作用于突触前腺苷受体发挥类似的抑制作用。
尽管之前已经研究了ATP和其他嘌呤的突触前抑制作用机制,但这些研究的对象通常是冷血动物的神经肌肉突触。少数在温血动物制剂上进行实验的研究描述了嘌呤的基本作用。这些研究通常受膈肌突触制备便利性的指导。我们认为这些结果不能被视为ATP和其他嘌呤对骨骼肌的典型作用,也不能外推到所有温血动物。此外,ATP及其衍生物在脊椎动物肌肉力量积累中的作用尚未得到研究。
已知在生理条件下,脊椎动物只能动员高达最大肌肉力量的三分之一。为什么三分之二的肌肉力量通常不被使用,但在应激时可以被使用,仍然未知。
已知身体对应激的适应性反应是内分泌系统活动发生变化。其中起主导作用的是儿茶酚胺和糖皮质激素,在应激状态下它们会大量动员到血液中。
我们之前发现,用氢化可的松孵育青蛙缝匠肌会导致收缩幅度降低。然而,当氢化可的松与ATP联合使用时,其对收缩反应的抑制作用消失。有趣的是,氢化可的松对腺苷的抑制作用没有影响。在接下来评估氢化可的松对大鼠比目鱼肌作用的实验中,发现氢化可的松和嘌呤具有相似的抑制作用。当ATP和氢化可的松一起使用时,会出现相同的抑制作用。
研究ATP和腺苷对大鼠骨骼肌收缩参数的影响,并评估儿茶酚胺对这些过程的影响。
使用英国Linton FSG - 01机械传感器按照标准程序等长记录大鼠比目鱼肌的收缩。将30秒内(30次反应)获得的肌肉参数平均值作为一个结果。估计曲线下降的幅度和时间特征。在所有实验过程中,标准Krebs溶液持续流过浴槽,并在必要浓度下添加试剂。所有实验动物均按照《欧洲保护用于科学实验的脊椎动物动物公约》进行饲养和准备解剖。本研究中使用的所有试剂均由英国Sigma Chemical Company Ltd.、Tocris Cookson和美国Research Biochemicals International提供。
100μM的腺苷浓度接近饱和[1],对于其前体ATP,该浓度是在脉冲通过突触后产生的[2]。我们使用该浓度的嘌呤来研究腺苷和ATP对神经肌肉突触的作用机制。
在存在100μM 8 - SPT(一种腺苷受体拮抗剂)的情况下,腺苷的作用部分受到抑制。在去甲肾上腺素存在的情况下,大鼠“快”和“慢”骨骼肌的收缩力提高了一半。在去甲肾上腺素存在的情况下,腺苷充分发挥其作用,但ATP对两块肌肉收缩力的抑制作用减半。
去甲肾上腺素使“快”和“慢”骨骼肌的收缩力降低幅度增加一倍。
在去甲肾上腺素存在的情况下,腺苷对收缩力的抑制作用得以维持。
在去甲肾上腺素存在的情况下,ATP对所研究骨骼肌收缩力的抑制作用减弱至原来的一半。
我们认为去甲肾上腺素降低ATP对骨骼肌的抑制作用可能是对急性应激的一种适应性反应。